Sexually Dimorphic Relationships Among Saa3 (Serum Amyloid A3), Inflammation, and Cholesterol Metabolism Modulate Atherosclerosis in Mice

Supplemental Digital Content is available in the text. Objective: Expression of the extrahepatic acute-phase protein Saa3 (serum amyloid A3) increases in response to acute and chronic inflammatory stimuli and is elevated in adipose tissue and macrophages in obese mice. A recent report suggested that Saa3 is proatherogenic in male ApoE−/− mice. Because of our previous observation that female but not male Saa3-deficient mice are protected from obesity, adipose inflammation, and hyperlipidemia, we sought to determine whether Saa3 differentially modulates atherosclerosis in mice of both sexes. Approach and Results: To promote atherosclerosis, Saa3+/+ and Saa3−/− male and female mice were crossed with Ldlr−/− mice. All mice consumed a diet high in saturated fat and sucrose with 0.15% added cholesterol for 16 weeks. Plasma lipids and atherosclerosis levels were assessed. Female Saa3−/−Ldlr−/− mice exhibited elevated cholesterol levels relative to Saa3+/+Ldlr−/− controls and exhibited increased atherosclerosis, while male Saa3−/−Ldlr−/− mice were protected from atherosclerosis. Data from the hybrid mouse diversity panel revealed that Saa3 associates strongly with inflammatory, Trem2-associated, and tissue remodeling genes and pathways in males but not females, an effect confirmed in liver tissue, atherosclerotic lesions, and cultured macrophages. Macrophages isolated from male and female mice showed differential inflammatory effects of Saa3 deficiency, an effect linked with sex steroid signaling. Cholesterol efflux capacity was increased in Saa3−/− males only. Conclusions: Saa3 is proatherogenic in male but atheroprotective in female mice, effects that may be related to sex-specific relationships between Saa3, cholesterol metabolism, inflammatory genes, and Trem2 macrophages.

[1]  T. Jones,et al.  Testosterone stimulates cholesterol clearance from human macrophages by activating LXRα. , 2021, Life sciences.

[2]  Mireya Becerra-Díaz,et al.  Androgen and Androgen Receptors as Regulators of Monocyte and Macrophage Biology in the Healthy and Diseased Lung , 2020, Frontiers in Immunology.

[3]  M. Cybulsky,et al.  Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas , 2020, Circulation research.

[4]  W. Altemeier,et al.  Presence of serum amyloid A3 in mouse plasma is dependent on the nature and extent of the inflammatory stimulus , 2020, Scientific Reports.

[5]  C. Glass,et al.  Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis. , 2020, Immunity.

[6]  L. Willemsen,et al.  Macrophage subsets in atherosclerosis as defined by single‐cell technologies , 2020, The Journal of pathology.

[7]  K. Bandow,et al.  Caldecrin inhibits lipopolysaccharide-induced pro-inflammatory cytokines and M1 macrophage polarization through the immunoreceptor triggering receptor expressed in myeloid cells-2. , 2020, Biochemical and biophysical research communications.

[8]  Steve Lianoglou,et al.  TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge , 2019, Neuron.

[9]  C. Ponting,et al.  Resolving the fibrotic niche of human liver cirrhosis at single cell level , 2019, Nature.

[10]  P. Libby,et al.  Low‐Dose Methotrexate for the Prevention of Atherosclerotic Events , 2019, The New England journal of medicine.

[11]  P. McNamara,et al.  Serum Amyloid A Is an Exchangeable Apolipoprotein , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[12]  P. Shridas,et al.  High-density lipoprotein inhibits serum amyloid A–mediated reactive oxygen species generation and NLRP3 inflammasome activation , 2018, The Journal of Biological Chemistry.

[13]  Dennis Wolf,et al.  Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis , 2018, Circulation research.

[14]  T. Jones,et al.  Randomized controlled trials – mechanistic studies of testosterone and the cardiovascular system , 2018, Asian journal of andrology.

[15]  J. Ather,et al.  Serum amyloid A3 is required for normal weight and immunometabolic function in mice , 2018, PloS one.

[16]  P. Shridas,et al.  Serum amyloid A3 is pro-atherogenic. , 2018, Atherosclerosis.

[17]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[18]  M. Koschinsky,et al.  Plasminogen promotes cholesterol efflux by the ABCA1 pathway. , 2017, JCI insight.

[19]  P. Scherer,et al.  Serum Amyloid A3 Gene Expression in Adipocytes is an Indicator of the Interaction with Macrophages , 2016, Scientific Reports.

[20]  G. Getz,et al.  Serum amyloid A and atherosclerosis , 2016, Current opinion in lipidology.

[21]  M. Harada‐Shiba,et al.  Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[22]  S. Subramanian,et al.  Serum amyloid A impairs the antiinflammatory properties of HDL. , 2016, The Journal of clinical investigation.

[23]  Brian J. Bennett,et al.  Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains , 2015, PLoS genetics.

[24]  A. Masi,et al.  Sexual Dimorphisms of Adrenal Steroids, Sex Hormones, and Immunological Biomarkers and Possible Risk Factors for Developing Rheumatoid Arthritis , 2015, International journal of endocrinology.

[25]  T. Vaisar,et al.  Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity[S] , 2015, Journal of Lipid Research.

[26]  G. Getz,et al.  Serum Amyloid A Facilitates Early Lesion Development in Ldlr−/− Mice , 2015, Journal of the American Heart Association.

[27]  Lindsey A. Muir,et al.  Differences in Hematopoietic Stem Cells Contribute to Sexually Dimorphic Inflammatory Responses to High Fat Diet-induced Obesity* , 2015, The Journal of Biological Chemistry.

[28]  G. Paulsson-Berne,et al.  The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability , 2014, Cardiovascular research.

[29]  S. Subramanian,et al.  Deletion of Serum Amyloid A3 Improves High Fat High Sucrose Diet-Induced Adipose Tissue Inflammation and Hyperlipidemia in Female Mice , 2014, PloS one.

[30]  K. Migita,et al.  Serum Amyloid A Induces NLRP-3-Mediated IL-1β Secretion in Neutrophils , 2014, PloS one.

[31]  A. Daugherty,et al.  Deficiency of Endogenous Acute Phase Serum Amyloid A Does Not Affect Atherosclerotic Lesions in Apolipoprotein E–Deficient Mice , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[32]  A. Goldberg,et al.  Decrease of Circulating SAA is Correlated with Reduction of Abdominal SAA Secretion During Weight Loss , 2013, Obesity.

[33]  Jason M. Meyer,et al.  The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A , 2013, Journal of lipids.

[34]  M. Rizzo,et al.  Recent Insights Into the Relationship Between Inflammatory Liver Diseases and Atherosclerosis , 2011, Journal of Investigative Medicine.

[35]  Katherine A. Fitzgerald,et al.  Serum Amyloid A Activates the NLRP3 Inflammasome and Promotes Th17 Allergic Asthma in Mice , 2011, The Journal of Immunology.

[36]  Robert L Wilensky,et al.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.

[37]  C. Zhang,et al.  Serum Amyloid A Directly Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice , 2011, Molecular medicine.

[38]  A. Villablanca,et al.  Atherosclerosis and sex hormones: current concepts. , 2010, Clinical science.

[39]  J. Eriksson,et al.  Association of serum amyloid A levels with adipocyte size and serum levels of adipokines: differences between men and women. , 2009, Cytokine.

[40]  P. Witting,et al.  Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. , 2009, Atherosclerosis.

[41]  Muredach P. Reilly,et al.  Inflammation Impairs Reverse Cholesterol Transport In Vivo , 2009, Circulation.

[42]  M. Fasshauer,et al.  The adipokine SAA3 is induced by interleukin‐1β in mouse adipocytes , 2008, Journal of cellular biochemistry.

[43]  Age K Smilde,et al.  Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis , 2007, Genome Biology.

[44]  S. Umemura,et al.  Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[45]  Da-Wei Gong,et al.  Acute-Phase Serum Amyloid A: An Inflammatory Adipokine and Potential Link between Obesity and Its Metabolic Complications , 2006, PLoS medicine.

[46]  A. Chait,et al.  Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[47]  P. Svensson,et al.  A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. , 2005, The Journal of clinical endocrinology and metabolism.

[48]  K. Clément,et al.  Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition , 2005, Diabetologia.

[49]  A. Chait,et al.  Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice , 2004, Circulation.

[50]  S. Reis,et al.  Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[51]  A. Whitehead,et al.  Serum amyloid A, the major vertebrate acute-phase reactant. , 1999, European journal of biochemistry.

[52]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[53]  J. Rotter,et al.  Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. , 1997, Circulation.

[54]  H. Khalili,et al.  Estradiol Down‐Regulates LPS‐Induced Cytokine Production and NFkB Activation in Murine Macrophages , 1997, American journal of reproductive immunology.

[55]  M. Frazier-Jessen,et al.  Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. , 1995, Journal of immunology.

[56]  R. Badolato,et al.  Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes , 1994, The Journal of experimental medicine.

[57]  S. Urieli-Shoval,et al.  Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  N. Eriksen,et al.  Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Drumm,et al.  Nonexpression of the human serum amyloid A three (SAA3) gene. , 1991, DNA and cell biology.

[60]  R. Meek,et al.  Amyloid A gene family expression in different mouse tissues , 1986, The Journal of experimental medicine.

[61]  J. Sipe,et al.  Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein , 1976, The Journal of experimental medicine.